Xeltis Bioabsorbable Pulmonary Valved Conduit Early Feasibility Study
To assess the survival rate of subjects at 6 and 12 months following implantation of the Bioabsorbable pulmonary valve conduit. To assess the rate of conduit failures at 6 months, requiring re-intervention or reoperation.